BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

763 related articles for article (PubMed ID: 32186756)

  • 1. Effects of cisplatin on the proliferation, invasion and apoptosis of breast cancer cells following β‑catenin silencing.
    Zhu X; Feng J; Fu W; Shu X; Wan X; Liu J
    Int J Mol Med; 2020 Jun; 45(6):1838-1850. PubMed ID: 32186756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miRNA-106a Promotes Breast Cancer Cell Proliferation, Clonogenicity, Migration, and Invasion Through Inhibiting Apoptosis and Chemosensitivity.
    You F; Luan H; Sun D; Cui T; Ding P; Tang H; Sun D
    DNA Cell Biol; 2019 Feb; 38(2):198-207. PubMed ID: 30570350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of LDOC1 on colorectal cancer cells via downregulation of the Wnt/β-catenin signaling pathway.
    Jiang J; Li Y; Jiang Z
    Oncol Rep; 2019 Jun; 41(6):3281-3291. PubMed ID: 31002361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL‑21/IL‑21R inhibit tumor growth and invasion in non‑small cell lung cancer cells via suppressing Wnt/β‑catenin signaling and PD‑L1 expression.
    Xue D; Yang P; Wei Q; Li X; Lin L; Lin T
    Int J Mol Med; 2019 Nov; 44(5):1697-1706. PubMed ID: 31573051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY; Xue M; Zhang QC; Su CF
    Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-Catenin signaling pathway regulates cisplatin resistance in lung adenocarcinoma cells by upregulating Bcl-xl.
    Zhang J; Liu J; Li H; Wang J
    Mol Med Rep; 2016 Mar; 13(3):2543-51. PubMed ID: 26860078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXO3a inhibits nephroblastoma cell proliferation, migration and invasion, and induces apoptosis through downregulating the Wnt/β‑catenin signaling pathway.
    Qian C; Liu Q
    Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34515328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of Meg3 enhances cisplatin resistance of lung cancer cells through activation of the WNT/β-catenin signaling pathway.
    Xia Y; He Z; Liu B; Wang P; Chen Y
    Mol Med Rep; 2015 Sep; 12(3):4530-4537. PubMed ID: 26059239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of mesenchymal stem cells on the apoptosis of breast cancer cells induced by cisplatin].
    Xu HT; Zhou Y; Li W; Zhang HH; Wu HY; Yang J
    Zhonghua Zhong Liu Za Zhi; 2017 Aug; 39(8):566-572. PubMed ID: 28835077
    [No Abstract]   [Full Text] [Related]  

  • 10. Silencing ARHGAP9 correlates with the risk of breast cancer and inhibits the proliferation, migration, and invasion of breast cancer.
    Wang T; Ha M
    J Cell Biochem; 2018 Sep; 119(9):7747-7756. PubMed ID: 29905031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. URG11 promotes proliferation and induced apoptosis of LNCaP cells.
    Sun C; Zhang G; Cheng S; Qian H; Li D; Liu M
    Int J Mol Med; 2019 May; 43(5):2075-2085. PubMed ID: 30864678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interference of Notch 1 inhibits the proliferation and invasion of breast cancer cells: Involvement of the β‑catenin signaling pathway.
    Lai XX; Li G; Lin B; Yang H
    Mol Med Rep; 2018 Feb; 17(2):2472-2478. PubMed ID: 29207146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FRZB knockdown upregulates β-catenin activity and enhances cell aggressiveness in gastric cancer.
    Qin S; Zhang Z; Li J; Zang L
    Oncol Rep; 2014 May; 31(5):2351-7. PubMed ID: 24676361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of lncRNA lnc-SLC4A1-1 induced by H3K27 acetylation promotes the development of breast cancer via activating CXCL8 and NF-kB pathway.
    Yi T; Zhou X; Sang K; Huang X; Zhou J; Ge L
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3765-3773. PubMed ID: 31556319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of long non‑coding RNA CCAT2 suppresses the progression of thyroid cancer by inhibiting the Wnt/β‑catenin pathway.
    Xin S; Ye X
    Int J Mol Med; 2020 Dec; 46(6):2047-2056. PubMed ID: 33125134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of Long Non-Coding RNA UCA1 Increases the Tamoxifen Sensitivity of Breast Cancer Cells through Inhibition of Wnt/β-Catenin Pathway.
    Liu H; Wang G; Yang L; Qu J; Yang Z; Zhou X
    PLoS One; 2016; 11(12):e0168406. PubMed ID: 27977766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of STAT3, β-Catenin, and Notch-1 by Single and Combinations of siRNA Treatment Enhance Chemosensitivity of Wild Type and Doxorubicin Resistant MCF7 Breast Cancer Cells to Doxorubicin.
    Alshaer W; Alqudah DA; Wehaibi S; Abuarqoub D; Zihlif M; Hatmal MM; Awidi A
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic Variation in MicroRNA-423 Promotes Proliferation, Migration, Invasion, and Chemoresistance in Breast Cancer Cells.
    Morales-Pison S; Jara L; Carrasco V; Gutiérrez-Vera C; Reyes JM; Gonzalez-Hormazabal P; Carreño LJ; Tapia JC; Contreras HR
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RFC3 induces epithelial‑mesenchymal transition in lung adenocarcinoma cells through the Wnt/β‑catenin pathway and possesses prognostic value in lung adenocarcinoma.
    Gong S; Qu X; Yang S; Zhou S; Li P; Zhang Q
    Int J Mol Med; 2019 Dec; 44(6):2276-2288. PubMed ID: 31661124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA LINC01287 promotes breast cancer cells proliferation and metastasis by activating Wnt/ß-catenin signaling.
    Song C; Sun P; He Q; Liu LL; Cui J; Sun LM
    Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4234-4242. PubMed ID: 31173295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.